Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma
LCH Da Cruz, I Rodriguez… - American Journal …, 2011 - Am Soc Neuroradiology
The current standard of care for newly diagnosed cases of high-grade glioma is surgical
resection followed by RT with concurrent chemotherapy. The most widely used criteria for …
resection followed by RT with concurrent chemotherapy. The most widely used criteria for …
Pseudoprogression: relevance with respect to treatment of high-grade gliomas
J Fink, D Born, MC Chamberlain - Current treatment options in oncology, 2011 - Springer
Opinion statement The post-treatment imaging assessment of high-grade gliomas remains
challenging notwithstanding the increased utilization of advanced MRI and PET imaging …
challenging notwithstanding the increased utilization of advanced MRI and PET imaging …
Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma
AA Thomas, J Arevalo-Perez, T Kaley, J Lyo… - Journal of neuro …, 2015 - Springer
Pseudoprogression may present as transient new or increasing enhancing lesions that
mimic recurrent tumors in treated glioblastoma. The purpose of this study was to examine …
mimic recurrent tumors in treated glioblastoma. The purpose of this study was to examine …
Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic …
AJ Prager, N Martinez, K Beal… - American Journal …, 2015 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Treatment-related changes and recurrent tumors often
have overlapping features on conventional MR imaging. The purpose of this study was to …
have overlapping features on conventional MR imaging. The purpose of this study was to …
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2–Radiological features and metric markers
C Le Fevre, JM Constans, I Chambrelant… - Critical reviews in …, 2021 - Elsevier
After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …
distinguished from true progression to correctly manage glioblastoma treatment and follow …
Shape features of the lesion habitat to differentiate brain tumor progression from pseudoprogression on routine multiparametric MRI: a multisite study
BACKGROUND AND PURPOSE: Differentiating pseudoprogression, a radiation-induced
treatment effect, from tumor progression on imaging is a substantial challenge in …
treatment effect, from tumor progression on imaging is a substantial challenge in …
[HTML][HTML] Incidence of tumour progression and pseudoprogression in high-grade gliomas: a systematic review and meta-analysis
AW Abbasi, HE Westerlaan, GA Holtman… - Clinical …, 2018 - Springer
Background High-grade gliomas are the most common primary brain tumours.
Pseudoprogression describes the false appearance of radiation-induced progression on …
Pseudoprogression describes the false appearance of radiation-induced progression on …
Pseudoprogression and pseudoresponse in the treatment of gliomas
D Brandsma, MJ van den Bent - Current opinion in neurology, 2009 - journals.lww.com
Both pseudo-phenomenona confuse the assessment of outcome of brain tumours in clinical
practice and in clinical trials. To overcome these issues, alternative endpoints and response …
practice and in clinical trials. To overcome these issues, alternative endpoints and response …
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
I Melguizo-Gavilanes, JM Bruner… - Journal of neuro …, 2015 - Springer
Pseudoprogression (psPD) refers to an increase in size or appearance of new areas of MRI
contrast enhancement soon after completing chemoradiation, timely diagnosis of which has …
contrast enhancement soon after completing chemoradiation, timely diagnosis of which has …
Longitudinal DSC-MRI for distinguishing tumor recurrence from pseudoprogression in patients with a high-grade glioma
JL Boxerman, BM Ellingson, S Jeyapalan… - American journal of …, 2017 - journals.lww.com
Objective: For patients with high-grade glioma on clinical trials it is important to accurately
assess time of disease progression. However, differentiation between pseudoprogression …
assess time of disease progression. However, differentiation between pseudoprogression …